The era of equity – or striving for it – is not about rewriting history. Nor is it about righting history’s myriad wrongs. History has happened. History is toast. History is, erm, history – in the ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a drug candidate aimed at treating apathy in patients with Parkinson’s disease ...

AlzeCure Pharma AB, a company specializing in drugs for nervous system diseases, announced that its abstract on NeuroRestore ACD856 has been accepted for presentation at the Clinical Trials in ...

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet ...